{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:54:51Z","timestamp":1790668491620,"version":"4.1.0"},"reference-count":26,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_hmbci-2026-0014_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to investigate the role of Human Leukocyte Antigen-G (HLA-G) gene expression, inflammatory cytokines, and hormonal profiles in the pathogenesis of recurrent pregnancy loss (RPL) and to assess their potential as diagnostic and predictive markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2026-0014_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A case-control study was conducted involving 240 women, including 120 with clinically confirmed RPL and 120 fertile controls. Serum levels of CRP (C-reactive protein) and IL-6 (interleukin-6) were measured using enzyme-linked immunosorbent assay (ELISA). Hormonal parameters, including thyroid-stimulating hormone (TSH), follicle-stimulating hormone (FSH), and luteinizing hormone (LH), were analyzed using chemiluminescence immunoassays (CLIA). HLA-G gene expression was quantified using quantitative real-time polymerase chain reaction (qRT-PCR). Statistical analyses included t-tests, receiver operating characteristic (ROC) curve analysis, and logistic regression to identify independent predictors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2026-0014_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>RPL cases showed significantly higher levels of TSH, FSH, CRP, and IL-6 and markedly lower HLA-G gene expression compared with controls (p &lt; 0.001). CRP showed the highest diagnostic accuracy (AUC = 0.997), followed by HLA-G (AUC = 0.938) and IL-6 (AUC = 0.896). Logistic regression identified IL-6, FSH, TSH, and HLA-G as independent predictors of RPL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2026-0014_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings highlight the interplay between immune dysfunction, hormonal imbalance, and reduced HLA-G expression in RPL. These markers may help in the early identification and risk assessment of RPL, with HLA-G showing potential for further investigation as a therapeutic target.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/hmbci-2026-0014","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:57:11Z","timestamp":1787057831000},"page":"101-108","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive analysis of HLA-G expression, hormonal profiles, and inflammatory markers in women with recurrent pregnancy loss"],"prefix":"10.1515","volume":"47","author":[{"given":"Simi","family":"Nadarajan","sequence":"first","affiliation":[{"name":"Meenakshi Academy of Higher Education and Research (Deemed to be University) , Chennai , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-1156","authenticated-orcid":false,"given":"Arumugam","family":"Suresh","sequence":"additional","affiliation":[{"name":"Scientist Cum Research Co-ordinator, Central Research Laboratory, Meenakshi Medical College & Research Institute, Meenakshi Academy of Higher Education and Research (Deemed to be University) , Kanchipuram , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7124-148X","authenticated-orcid":false,"given":"Dinesh Roy","family":"Divakaran","sequence":"additional","affiliation":[{"name":"CEO & Senior Cytogeneticist, Genetika, Centre for Advanced Genetic Studies , Thiruvananthapuram , Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natrajan","family":"Muninathan","sequence":"additional","affiliation":[{"name":"Central Research Laboratory, Meenakshi Medical College Hospital and Research Institute, Meenakshi Academy of Higher Education and Research (Deemed to be University) , Kanchipuram , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venugopal","family":"Gopikrishnan","sequence":"additional","affiliation":[{"name":"Center for Drug Discovery and Development, Sathyabhama Institute of Science and Technology , Chennai , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeena","family":"Jose","sequence":"additional","affiliation":[{"name":"Meenakshi Academy of Higher Education and Research (Deemed to be University) , Chennai , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswathi Palakkattu","family":"Veetil","sequence":"additional","affiliation":[{"name":"Meenakshi Academy of Higher Education and Research (Deemed to be University) , Chennai , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"2026092906561149794_j_hmbci-2026-0014_ref_001","doi-asserted-by":"crossref","unstructured":"Sultana, S, Nallari, P, Ananthapur, V. Recurrent pregnancy loss (RPL): an overview. J\u00a0Womens Healt Develop 2020;3:302\u201315.","DOI":"10.26502\/fjwhd.2644-28840038"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_002","doi-asserted-by":"crossref","unstructured":"Singh, A, Khatuja, R, Verma, M. Background, epidemiology and definition of recurrent pregnancy loss. In: Recurrent Pregn Loss. Singapore: Springer Singapore; 2017, 6:3\u201312 pp.","DOI":"10.1007\/978-981-10-7338-0_1"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_003","doi-asserted-by":"crossref","unstructured":"Cao, C, Bai, S, Zhang, J, Sun, X, Meng, A, Chen, H, et al.. Understanding recurrent pregnancy loss: recent advances on its etiology, clinical diagnosis, and management. Medical Rev 2023;2:570\u201389. https:\/\/doi.org\/10.1515\/mr-2022-0030.","DOI":"10.1515\/mr-2022-0030"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_004","doi-asserted-by":"crossref","unstructured":"Aslanian-Kalkhoran, L, Kamrani, A, Alipourfard, I, Chakari-Khiavi, F, Chakari-Khiavi, A, Aghebati-Maleki, L, et al.. The effect of lymphocyte immunotherapy (LIT) in modulating immune responses in patients with recurrent pregnancy loss (RPL). Int Immunopharmacol 2023;121:110326. https:\/\/doi.org\/10.1016\/j.intimp.2023.110326.","DOI":"10.1016\/j.intimp.2023.110326"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_005","doi-asserted-by":"crossref","unstructured":"Lash, GE, Raghupathy, R. Immune involvement in recurrent pregnancy loss. Front Immunol 2023;14:1330701. https:\/\/doi.org\/10.3389\/fimmu.2023.1330701.","DOI":"10.3389\/fimmu.2023.1330701"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_006","doi-asserted-by":"crossref","unstructured":"Vomstein, K, Feil, K, Strobel, L, Aulitzky, A, Hofer-Tollinger, S, Kuon, RJ, et al.. Immunological risk factors in recurrent pregnancy loss: guidelines versus current state of the art. J\u00a0Clin Med 2021;10:869. https:\/\/doi.org\/10.3390\/jcm10040869.","DOI":"10.3390\/jcm10040869"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_007","doi-asserted-by":"crossref","unstructured":"Aliyeva, G, Tarverdiyeva, S, Ibrahimov, M. New aspects of immunological risk factors in the treatment of recurrent pregnancy loss. Heal Low-Res Set 2024;12.","DOI":"10.4081\/hls.2024.12563"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_008","doi-asserted-by":"crossref","unstructured":"Zhuang, B, Shang, J, Yao, Y. HLA-G: an important mediator of maternal-fetal immune-tolerance. Front Immunol 2021;12:744324. https:\/\/doi.org\/10.3389\/fimmu.2021.744324.","DOI":"10.3389\/fimmu.2021.744324"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_009","doi-asserted-by":"crossref","unstructured":"Ferreira, LM, Meissner, TB, Tilburgs, T, Strominger, JL. HLA-G: at the interface of maternal\u2013fetal tolerance. Trends Immunol 2017;38:272\u201386. https:\/\/doi.org\/10.1016\/j.it.2017.01.009.","DOI":"10.1016\/j.it.2017.01.009"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_010","doi-asserted-by":"crossref","unstructured":"Mao, J, Feng, Y, Zhu, X, Ma, F. The molecular mechanisms of HLA-G regulatory function on immune cells during early pregnancy. Biomolecules 2023;13:1213. https:\/\/doi.org\/10.3390\/biom13081213.","DOI":"10.3390\/biom13081213"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_011","doi-asserted-by":"crossref","unstructured":"Piccinni, MP, Raghupathy, R, Saito, S, Szekeres-Bartho, J. Cytokines, hormones and cellular regulatory mechanisms favoring successful reproduction. Front Immunol 2021;12:717808. https:\/\/doi.org\/10.3389\/fimmu.2021.717808.","DOI":"10.3389\/fimmu.2021.717808"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_012","doi-asserted-by":"crossref","unstructured":"Yang, X, Tian, Y, Zheng, L, Luu, T, Kwak-Kim, J. The update immune-regulatory role of pro-and anti-inflammatory cytokines in recurrent pregnancy losses. Int J Mol Sci 2022;24:132. https:\/\/doi.org\/10.3390\/ijms24010132.","DOI":"10.3390\/ijms24010132"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_013","doi-asserted-by":"crossref","unstructured":"Kniotek, M, Zych, M, Roszczyk, A, Szafarowska, M, Jerzak, MM. Decreased production of TNF-\u03b1 and IL-6 inflammatory cytokines in non-pregnant idiopathic RPL women immunomodulatory effect of sildenafil citrate on the cellular response of idiopathic RPL women. J\u00a0Clin Med 2021;10:3115. https:\/\/doi.org\/10.3390\/jcm10143115.","DOI":"10.3390\/jcm10143115"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_014","doi-asserted-by":"crossref","unstructured":"Chomczynski, P, Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156\u20139. https:\/\/doi.org\/10.1006\/abio.1987.9999.","DOI":"10.1016\/0003-2697(87)90021-2"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_015","doi-asserted-by":"crossref","unstructured":"Bustin, SA, Mueller, R. Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin Sci 2005;109:365\u201379. https:\/\/doi.org\/10.1042\/CS20050086.","DOI":"10.1042\/CS20050086"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_016","doi-asserted-by":"crossref","unstructured":"Engvall, E. The ELISA, enzyme-linked immunosorbent assay. Clin Chem 2010;56:319\u201320. https:\/\/doi.org\/10.1373\/clinchem.2009.127803.","DOI":"10.1373\/clinchem.2009.127803"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_017","doi-asserted-by":"crossref","unstructured":"Soldin, OP, Hoffman, EG, Waring, MA, Soldin, SJ. Pediatric reference intervals for FSH, LH, estradiol, T3, free T3, cortisol, and growth hormone on the DPC IMMULITE 1000. Clin Chim Acta 2005;355:205\u201310. https:\/\/doi.org\/10.1016\/j.cccn.2005.01.006.","DOI":"10.1016\/j.cccn.2005.01.006"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_018","doi-asserted-by":"crossref","unstructured":"Al Achkar, A, Naous, E, Salameh, C, Cordahi, CC, Germanos-Haddad, M, Sleilaty, G, et al.. Comparison of thyroid stimulating hormone, free thyroxine, total triiodothyronine, thyroglobulin and peroxidase antibodies measurements by two different platforms. Clin Chem Lab Med 2022;60:e190\u20134. https:\/\/doi.org\/10.1515\/cclm-2022-0139.","DOI":"10.1515\/cclm-2022-0139"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_019","doi-asserted-by":"crossref","unstructured":"Shi, L, Cui, L, Yang, L, He, L, Jia, L, Bai, W, et al.. Hotspots and frontiers in luteal phase defect research: an in-depth global trend bibliometric and visualization analysis over a 52-year period. Heliyon 2024;10.","DOI":"10.1016\/j.heliyon.2024.e35088"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_020","doi-asserted-by":"crossref","unstructured":"Tesarik, J, Conde-L\u00f3pez, C, Gal\u00e1n-L\u00e1zaro, M, Mendoza-Tesarik, R. Luteal phase in assisted reproductive technology. Frontiers in Reproduct Healt 2020;2:595183. https:\/\/doi.org\/10.3389\/frph.2020.595183.","DOI":"10.3389\/frph.2020.595183"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_021","doi-asserted-by":"crossref","unstructured":"Zhang, L, Du, Y, Zhou, J, Li, J, Shen, H, Liu, Y, et al.. Diagnostic workup of endocrine dysfunction in recurrent pregnancy loss: a cross-sectional study in Northeast China. Front Endocrinol 2023;14:1215469. https:\/\/doi.org\/10.3389\/fendo.2023.1215469.","DOI":"10.3389\/fendo.2023.1215469"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_022","doi-asserted-by":"crossref","unstructured":"Racoubian, E, Aimagambetova, G, Finan, RR, Almawi, WY. Age-dependent changes in Anti-M\u00fcllerian hormone levels in Lebanese females: correlation with basal FSH and LH levels and LH\/FSH ratio: a cross-sectional study. BMC Womens Health 2020;20:134. https:\/\/doi.org\/10.1186\/s12905-020-00998-4.","DOI":"10.1186\/s12905-020-00998-4"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_023","doi-asserted-by":"crossref","unstructured":"Jameel, S, Bhuwalka, R, Begum, M, Bonu, R, Jahan, P. Circulating levels of cytokines (IL-6, IL-10 and TGF-\u03b2) and CD4+ CD25+ FOXP3+ treg cell population in recurrent pregnancy loss. Reprod Biol 2024;24:100842. https:\/\/doi.org\/10.1016\/j.repbio.2023.100842.","DOI":"10.1016\/j.repbio.2023.100842"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_024","doi-asserted-by":"crossref","unstructured":"Mishra, S, Ashish, A, Rai, S, Sahni, C, Tiwari, S, Kumar, B, et al.. The impact of inflammatory cytokines on recurrent pregnancy loss: a preliminary investigation. Reprod Sci 2025;32:804\u201314. https:\/\/doi.org\/10.1007\/s43032-025-01786-x.","DOI":"10.1007\/s43032-025-01786-x"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_025","doi-asserted-by":"crossref","unstructured":"Moqadami, A, Khalaj\u2010Kondori, M, Haghi, M. Association of HLA\u2010G 3\u2032\u2010UTR haplotypes with recurrent spontaneous abortion in women from Northwest Iran. Birth Defects Res 2024;116:e2418. https:\/\/doi.org\/10.1002\/bdr2.2418.","DOI":"10.1002\/bdr2.2418"},{"key":"2026092906561149794_j_hmbci-2026-0014_ref_026","doi-asserted-by":"crossref","unstructured":"Khani, H, Feizi, MA, Safaralizadeh, R, Mohseni, J, Haghi, M. Altered expression of the HLA-G and IL10RB genes in placental tissue of women with recurrent pregnancy loss. Clin Lab 2023;69. https:\/\/doi.org\/10.7754\/Clin.Lab.2022.220822.","DOI":"10.7754\/Clin.Lab.2022.220822"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2026-0014\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2026-0014\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:56:33Z","timestamp":1790664993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2026-0014\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7,8]]},"published-print":{"date-parts":[[2026,9,30]]}},"alternative-id":["10.1515\/hmbci-2026-0014"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2026-0014","relation":{},"ISSN":["1868-1883","1868-1891"],"issn-type":[{"value":"1868-1883","type":"print"},{"value":"1868-1891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]}}}